Gene · 79109
Papers2,634
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,634
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Clinical Classification of Obesity and Implications for Metabolic Dysfunction-Associated Fatty Liver Disease and Treatment. | Diabetes Metab Syndr Obes | 2023 | 37905232 | PubTator, text mining | PubMed |
| Modulation of EGFR Activity by Molecularly Imprinted Polymer Nanoparticles Targeting Intracellular Epitopes. | Nano Lett | 2023 | 37902816 | PubTator, text mining | PubMed |
| mTORC1 and SGLT2 Inhibitors-A Therapeutic Perspective for Diabetic Cardiomyopathy. | Int J Mol Sci | 2023 | 37894760 | PubTator, text mining | PubMed |
| NADPH Oxidases and Oxidative Stress in the Pathogenesis of Atrial Fibrillation. | Antioxidants (Basel) | 2023 | 37891912 | PubTator, text mining | PubMed |
| L-Type Amino Acid Transporter 1 (LAT1) Promotes PMA-Induced Cell Migration through mTORC2 Activation at the Lysosome. | Cells | 2023 | 37887348 | PubTator, text mining | PubMed |
| Unmasking the tumourigenic role of SIN1/MAPKAP1 in the mTOR complex 2. | Clin Transl Med | 2023 | 37877351 | PubTator, text mining | PubMed |
| Polygenic predisposition, sleep duration, and depression: evidence from a prospective population-based cohort. | Transl Psychiatry | 2023 | 37857612 | PubTator, text mining | PubMed |
| Stress mechanism involved in the progression of alcoholic liver disease and the therapeutic efficacy of nanoparticles. | Front Immunol | 2023 | 37841267 | PubTator, text mining | PubMed |
| The Classic Three-Month Post-Operative Adaptation Phase in Foot and Ankle Surgery-An Expert Perspective. | J Clin Med | 2023 | 37834861 | PubTator, text mining | PubMed |
| Autophagy as a Target for Non-Immune Intrinsic Functions of Programmed Cell Death-Ligand 1 in Cancer. | Int J Mol Sci | 2023 | 37834467 | PubTator, text mining | PubMed |
| Unveiling Novel Avenues in mTOR-Targeted Therapeutics: Advancements in Glioblastoma Treatment. | Int J Mol Sci | 2023 | 37834408 | PubTator, text mining | PubMed |
| Mesenchymal Stem Cells in the Treatment of COVID-19. | Int J Mol Sci | 2023 | 37834246 | PubTator, text mining | PubMed |
| Tripartite motif containing 26 prevents steatohepatitis progression by suppressing C/EBPδ signalling activation. | Nat Commun | 2023 | 37821436 | PubTator, text mining | PubMed |
| High blood galectin-3 level associated with risk of frailty in aging. | Front Endocrinol (Lausanne) | 2023 | 37818088 | PubTator, text mining | PubMed |
| Mechanistic target of rapamycin (mTOR): a potential new therapeutic target for rheumatoid arthritis. | Arthritis Res Ther | 2023 | 37784141 | PubTator, text mining | PubMed |
| Multifaceted role of mTOR (mammalian target of rapamycin) signaling pathway in human health and disease. | Signal Transduct Target Ther | 2023 | 37779156 | PubTator, text mining | PubMed |
| The intricate role of CCL5/CCR5 axis in Alzheimer disease. | J Neuropathol Exp Neurol | 2023 | 37769321 | PubTator, text mining | PubMed |
| Insights on Antitumor Activity and Mechanism of Natural Benzophenanthridine Alkaloids. | Molecules | 2023 | 37764364 | PubTator, text mining | PubMed |
| Epithelial-Immune Cell Crosstalk Determines the Activation of Immune Cells In Vitro by the Human Cathelicidin LL-37 at Low Physiological Concentrations. | Biomolecules | 2023 | 37759716 | PubTator, text mining | PubMed |
| Protein interaction network analysis of mTOR signaling reveals modular organization. | J Biol Chem | 2023 | 37741456 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/79109/papers?page=5